ADAMTS2 and neoplasm: This potential role of ADAMTS2, -3, and -14 may be of importance in conditions where abnormal lymphangiogenesis is part of the pathology (e.g., tumor aggressiveness), as a blockade of these enzymes could then be a potential therapeutic strategy in these conditions.